Cargando…

Predicting dynamic response to neoadjuvant chemotherapy in breast cancer: a novel metabolomics approach

Neoadjuvant chemotherapy (NACT) outcomes vary according to breast cancer (BC) subtype. Since pathologic complete response is one of the most important target endpoints of NACT, further investigation of NACT outcomes in BC is crucial. Thus, identifying sensitive and specific predictors of treatment r...

Descripción completa

Detalles Bibliográficos
Autores principales: Díaz, Caridad, González‐Olmedo, Carmen, Díaz‐Beltrán, Leticia, Camacho, José, Mena García, Patricia, Martín‐Blázquez, Ariadna, Fernández‐Navarro, Mónica, Ortega‐Granados, Ana Laura, Gálvez‐Montosa, Fernando, Marchal, Juan Antonio, Vicente, Francisca, Pérez del Palacio, José, Sánchez‐Rovira, Pedro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9297806/
https://www.ncbi.nlm.nih.gov/pubmed/35338693
http://dx.doi.org/10.1002/1878-0261.13216